Skip to main content
Equibles
ALGN logo

ALGN · Align Technology Inc

Track ALGN — free

Use ALGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$159.86 +0.71 (+0.44%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.31B
Shares
71.04M

ALGN metrics

78 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$159.15
Market cap
$11.31B

Price action

19 metrics
Price change (1W)
+0.0%
Price change (30D)
-8.1%
Price change (3M)
-1.6%
Price change (6M)
-12.6%
Price change (YTD)
+1.9%
Price change (1Y)
+16.0%
Trailing year
Price change (5Y)
-78.2%
52-week high
$197.51
52-week low
$124.88
Change from 52-week high
-19.4%
Change from 52-week low
+27.4%
Annualized volatility
39.4%
Beta
1.4
RSI (14D)
42.1
Price vs SMA 50
-7.4%
Price vs SMA 200
-6.5%
Avg volume (3M)
963,891
Relative volume
0.7
Average dollar volume
$166.50M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
71.04M

Valuation

12 metrics
P / E (TTM)
27.7
Trailing earnings · reciprocal yield 3.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.7×
reciprocal yield 36.6%
P / book
2.7
reciprocal yield 37.4%
FCF yield
5.6%
TTM · current market cap
Buyback yield
2.4%
P / FCF
17.8
reciprocal yield 5.6%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
35.3×
reciprocal yield 2.8%
P / E historical average (5Y)
43.9×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
68.0%
Operating margin
13.2%
Trailing 12 months
Net margin
10.0%
Gross profit (TTM)
$2.82B
Operating profit (TTM)
$547.59M
Net income (TTM)
$413.58M
Trailing 12 months
Diluted EPS (TTM)
$5.74
FCF margin
15.3%
Effective tax rate
27.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$5.21

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
-13.1%
Revenue (TTM)
$4.14B
Trailing 12 months
EPS growth YoY
-12.2%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+10.3%
EPS CAGR (3Y)
+7.0%
EPS CAGR (5Y)
-24.1%
FCF CAGR (3Y)
+21.0%
FCF CAGR (5Y)
-0.7%

Quality

14 metrics
Return on equity
9.8%
Return on assets
6.4%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
$801.98M
Free cash flow (TTM)
$633.57M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.10B
Total assets
$6.42B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$755.70M
Capital expenditures (TTM)
$122.13M
R&D (TTM)
$377.00M
SG&A (TTM)
$1.79B
Stock compensation (TTM)
$179.15M
R&D / revenue
9.1%
Stock compensation / revenue
4.3%

Ownership (13F)

3 metrics
13F filers
679
13F filer change QoQ
-21
Institutional ownership
103.7%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1097149 CUSIP 016255101 13F (30d) 436 filings 431 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)